Rapid Medical, a developer of neurovascular devices, announced the first successful robotic thrombectomy in Medellín, Colombia. Two patients were treated with the Robotic TIGERTRIEVER, what the company called the first endovascular thrombectomy device that adapts autonomously to the patient’s anatomy.
“Automating stroke procedures is a significant advancement for the medical field,” said Dr. Boris Pabón, the endovascular neurosurgeon at Angiosur who performed the first-in-man procedures. “Robotic clot removal achieves a level of precision that surpasses interventional capabilities. The robotic TIGERTRIEVER gives me direct insight into the vessel characteristics and senses what I cannot–truly remarkable.”
The AI-activated TIGERTRIEVER captures the blockage with active integration. The device’s radial force is then automatically reduced to minimize trauma to the brain as it is retrieved. This builds upon the excellent clinical results and procedure times seen with TIGERTRIEVER’s adjustability, further enhancing precision and streamlining workflow.
“Implementing this technology is a testament to our commitment to expanding treatment for stroke patients worldwide,” said Ronen Eckhouse, CEO of Rapid Medical. “We are at the forefront of advancing care—first by providing physicians with active technology and now paving a new pathway to automate procedures with intelligent control.”
